E Fund Management Co., Ltd. Clovis Oncology, Inc. Transaction History

E Fund Management Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.43 - $3.14 $62,390 - $136,998	-43,630 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.7 - $4.76 $11,056 - $19,492	4,095 Added 10.36%	43,630 $118,000
Q3 2021 Nov 12, 2021	BUY	$4.06 - $5.8 $65,739 - $93,913	16,192 Added 69.37%	39,535 $176,000
Q1 2021 May 12, 2021	BUY	$4.81 - $10.34 $112,279 - $241,366	23,343 New	23,343 $163,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.